Bluebird bio Inc [BLUE] Revenue clocked in at $21.73 million, down -33.09% YTD: What’s Next?
Bluebird bio Inc [NASDAQ: BLUE] price surged by 0.07 percent to reach at $0.0. The one-year BLUE stock forecast points to a potential upside of 75.6. The average equity rating for BLUE stock is currently 2.77, trading closer to a bullish pattern in the stock